TB Research Funding Topped $900M In 2019, New Report Examining Funding Trends Since 2005 Shows

Treatment Action Group: Tuberculosis Research Funding Trends 2005-2019
“Global funding for tuberculosis (TB) research totaled over US$900 million in 2019, the second highest level on record, according to a report released [Monday] by Treatment Action Group (TAG) and the United Nations-hosted Stop TB Partnership. The report — Tuberculosis Research Funding Trends, 2005-2019 — presents new data on 2019 funding for TB research and development (R&D) and analyzes trends in investment since 2005. TB killed more people than any other single infectious agent in 2019. The figures for 2019 provide a last look at funding for TB R&D before the devastating emergence of the COVID-19 pandemic in 2020, an event whose full effect on the research landscape for TB and other infectious diseases will only be known in a few years’ time…” (12/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.